123802-72-2

Upstream product

• 123803-36-1 (3R,4S,5R)-4-Benzyloxy-5-cyclohexylmethyl-2-methoxy-tetrahydro-furan-3-ol 
• 63593-02-2 3-O-benzyl-1,2-O-isopropylidene-α-D-ribo-pentodialdo-1,4-furanose 
• 10024-89-2 morpholin hydrochloride 
• 123802-71-1 (2R,3R,4R)-3,4-Bis-benzyloxy-2-cyclohexylmethyl-5-methoxy-tetrahydro-furan 
• 123802-70-0 3-O-benzyl-5-cyclohexylidene-5-deoxy-1,2-O-isopropylidene-α-D-ribofuranose 
• 123803-35-0 3-O-benzyl-5-cyclohexyl-5-deoxy-1,2-O-isopropylidene-α-D-ribofuranose 

Downstream Products

• 123878-50-2 (2S,3R,4S)-4-Amino-5-cyclohexyl-1-morpholino-2,3-pentanediol 
• 120716-81-6 (2S,3R,4S)-4--L-norleucyl>amino-5-cyclohexyl-1-morpholino-2,3-pentadienol 

Relevant academic research and scientific papers

N-ACYLAMINO ACID DERIVATIVES AND THEIR PHARMACEUTICAL COMPOSITIONS

An N-acylamino acid derivative of the formula: STR1 wherein the substituents are herein defined or a salt thereof, which is useful as hypotensive drugs.

A STEREOSPECIFIC SYNTHESIS OF A RENIN INHIBITOR (BW-175) WHICH INCORPORATES A SULFONEMETHYLENE ISOSTERE AND A DIHYDROXYETHYLENE ISOSTERE.

(2R,3R,4S)-4-norleucyl>amino-5-cyclohexyl-1-morpholino-2,3-pentanediol (BW-175) was synthesized stereospecifically.